Enhertu improves both progression-free and overall survival in Destiny-Breast04 trial in patients with HER2-low metastatic breast cancer Read more
Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet Read more
BD launches its second Centre of Excellence in flow cytometry for clinical research at CMC, Vellore Read more